Anika Therapeutics Inc (ANIK)

EBITDA Growth

173.10%

TTM · Period ending:

ANIK logo

ANIK EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported173.10%
ANIK TTM EBITDA YoY % (-16.67% → 173.10%)
High-resolution chart · PNG

ANIK ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Anika Therapeutics Inc EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
-600.9259%
-1,226.8506%
-79.2543%
-219.715%
-123.5359%
-102.4297%
-74.7964%
-74.479%
-60.1188%
2.5%
10.8108%
3,300%
1,220%
350%
227.5862%
92%
82.1429%
38.4615%
-70.5882%
-47.0588%
-115.3846%
-85.7143%
-13.3333%
-41.6667%
0%
-16.6667%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.